Bliss GVS Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 31, 2025 along with the Voting Results.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma Limited has filed the voting results of its 40th Annual General Meeting held on July 31, 2025, conducted via video conferencing, along with the Scrutinizer's Report from M/s. AVS & Associates. Four resolutions were put to vote, and all passed with near-unanimous support. Resolution 1 (adoption of audited standalone and consolidated financial statements for FY25) passed with 100% in favour on 6.14 crore shares polled (58.21% of outstanding shares). Resolution 2 confirmed a final dividend of ₹0.50 per share (50% on face value of ₹1) for FY25, also with 100% in favour. Resolution 3 re-appointed Dr. Vibha Gagan Sharma (DIN: 02307289) as director with 99.99% support. Resolution 4 appointed M/s. AVS & Associates as secretarial auditors with 100% in favour. A total of 46,979 shareholders were on record as of July 24, 2025; 95 attended via VC (4 promoter group, 91 public).
All routine AGM items approved without dissent, confirming the ₹0.50 per share dividend for FY25 and continuity of board composition. No governance red flags from shareholders; voting turnout was moderate at ~58% of outstanding equity.